Emcure Pharmaceuticals Ltd vs Sigachi Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1660 as of 06 May 15:30 . The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 29.8 on March 2025 to 29.8 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 19.3 on March 2025 . This represents a CAGR of -3.44% over 4 years The Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 20327 crore on March 2025 to ₹ 20327 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1342 crore on March 2025 . This represents a CAGR of 10.85% over 4 years The revenue of Emcure Pharmaceuticals Ltd for the Mar '26 is ₹ 2484 crore as compare to the Dec '25 revenue of ₹ 2365 crore. This represent the growth of 5.02% The revenue of Sigachi Industries Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 117.68 crore. This represent the decline of -100% The ebitda of Emcure Pharmaceuticals Ltd for the Mar '26 is ₹ 493.84 crore as compare to the Dec '25 ebitda of ₹ 456.45 crore. This represent the growth of 8.19% The ebitda of Sigachi Industries Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 5.45 crore. This represent the decline of -100% The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 152.59 crore to ₹ 243.74 crore over 8 quarters. This represents a CAGR of 26.39% The net profit of Sigachi Industries Ltd changed from ₹ 12.76 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Emcure Pharmaceuticals Ltd changed from 4.3 % on March 2021 to 17.92 % on March 2025 . This represents a CAGR of 33.04% over 5 yearsThe Dividend Payout of Sigachi Industries Ltd changed from 8.08 % on March 2022 to 8.02 % on March 2025 . This represents a CAGR of -0.19% over 4 years .

About Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics.

About Sigachi Industries Ltd

Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
To diversify the business activities, the name of Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
Subsequently, it was converted from a Private Limited to a Public Limited and the name was changed to 'Sigachi Industries Limited' on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

FAQs for the comparison of Emcure Pharmaceuticals Ltd and Sigachi Industries Ltd

Which company has a larger market capitalization, Emcure Pharmaceuticals Ltd or Sigachi Industries Ltd?

Market cap of Emcure Pharmaceuticals Ltd is 31,471 Cr while Market cap of Sigachi Industries Ltd is 765 Cr

What are the key factors driving the stock performance of Emcure Pharmaceuticals Ltd and Sigachi Industries Ltd?

The stock performance of Emcure Pharmaceuticals Ltd and Sigachi Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emcure Pharmaceuticals Ltd and Sigachi Industries Ltd?

As of May 6, 2026, the Emcure Pharmaceuticals Ltd stock price is INR ₹1660.0. On the other hand, Sigachi Industries Ltd stock price is INR ₹20.02.

How do dividend payouts of Emcure Pharmaceuticals Ltd and Sigachi Industries Ltd compare?

To compare the dividend payouts of Emcure Pharmaceuticals Ltd and Sigachi Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.